ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.

Publication

ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.

Journal Paper/Review - Oct 24, 2024

Cerminara Sara Elisa, Cvijetic Ivana, Huber Stephanie, Mueller Simon M, Kostner Lisa, Goessinger Elisabeth V, Narainsing Jasmin, Dutilh Gilles, Heidemeyer Kristine, Yawalkar Nikhil, Conrad Curdin, Plaza Tobias, Maul Julia-Tatjana, Cozzio Antonio, Navarini Alexander A

Citation

Cerminara S, Cvijetic I, Huber S, Mueller S, Kostner L, Goessinger E, Narainsing J, Dutilh G, Heidemeyer K, Yawalkar N, Conrad C, Plaza T, Maul J, Cozzio A, Navarini A. ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis. J Eur Acad Dermatol Venereol 2024

Type

Journal Paper/Review (English)

Journal

J Eur Acad Dermatol Venereol 2024

Publication Date

Oct 24, 2024

Issn Electronic

1468-3083